Table 3.
Univariate analysis |
Multivariate analysis |
|||
---|---|---|---|---|
Hazard ratio (95% CI) | p-value | Hazard ratio (95% CI) | p-value | |
Histologic grade (1&2 vs. 3) | 0.914 (0.474-1.762) | 0.788 | 1.364 (0.696-2.685) | 0.364 |
pT (3&4 vs. 1&2) | 2.129 (1.009-4.492) | 0.047 | 1.788 (0.828-3.860) | 0.139 |
Tumor-infiltrating lymphocytes (%) | ||||
< 10 | 1 | 0.003 | 1 | 0.014 |
10-30 | 0.815 (0.427-1.557) | 0.536 | 0.874 (0.442-1.730) | 0.699 |
30-60 | 0.630 (0.310-1.278) | 0.200 | 0.635 (0.300-1.343) | 0.235 |
> 60 | 0.198 (0.082-0.477) | < 0.001 | 0.231 (0.091-0.587) | 0.002 |
Cytoplasmic LMP7 expression | ||||
None | 1 | 0.107 | 1 | 0.726 |
Low | 0.827 (0.444-1.542) | 0.551 | 0.940 (0.487-1.813) | 0.853 |
High | 0.483 (0.239-0.978) | 0.043 | 0.752 (0.355-1.594) | 0.457 |
TNBC, triple-negative breast cancer; CI, confidence interval.